Loading asset research
Madrigal Pharmaceuticals Inc. Common Stock
MDGLNasdaq · USD · StocksQuote as of · Exchange session not verified$533.93
+0.15%
Today
MDGL
Loading 1D prices…
Market cap
$12.3B
Volume
187.6K
52w high
$615.0052w low
$393.61Company profile
Madrigal Pharmaceuticals Inc. Common Stock
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
West Conshohocken, PA, United States
Employees
915
Fiscal year end
1231
CIK
1157601
Session & valuation
Open$536.02
Previous close$533.12
Day high$546.56
Day low$531.37
30-day avg. volume280.3K
Outstanding shares23.1M
Diluted EPS-$10.15
Latest annual period
P/E (trailing)-52.60
P/E (forward)55.53
Price / book23.57
Beta-0.99
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CORTCorcept Therapeutics Incorporated Common Stock | $12.2B | $761.4M | +13.09% | $0.82 | -1.83% | Buy |
| BMRNBioMarin Pharmaceutical Inc. Common Stock | $12.7B | $3.2B | +10.83% | $1.80 | +0.26% | Buy |
| ARWRArrowhead Pharmaceuticals Inc. Common Stock | $11.7B | $413M | -71.72% | -$2.10 | +0.14% | Buy |
| ELANElanco Animal Health Incorporated Common Stock | $11.6B | $4.7B | -4.92% | -$0.47 | +1.36% | Buy |
| AXSMAxsome Therapeutics Inc. Common Stock | $11.6B | $638.5M | -28.69% | -$3.68 | +4.61% | Buy |